- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-11-0026734

About Bailee Pharmaceuticals Private Limited
Data last updated:
Bailee Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC390117.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Suman Kumar Choudhary and Abha Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.1479 Durga Mandir Block Tirthankar Nagar, Jain Nagar Village Karala, Delhi, India – 110081.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.57 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹6.42 Lakh (net margin -55.5%) and EBITDA of -₹6.4 Lakh (EBITDA margin -55.3%). Revenue has grown at a compounded annual rate (CAGR) of 128% over three years.
Bailee Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0026734). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website baileepharmaceuticals.com.
Company details
Recognitions & Rankings of Bailee Pharmaceuticals
Contact details
Bailee Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressH No.1479 Durga Mandir Block Tirthankar Nagar, Jain Nagar Village Karala, Delhi, India – 110081
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bailee Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Bailee Pharmaceuticals Private Limited, buy the company report.
Financials of Bailee Pharmaceuticals Private Limited
FY 2025 filings availableBailee Pharmaceuticals Private Limited reported revenue of ₹11.57 Lakh (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 34% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 128%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹6.4 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹6.42 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -55.3% | |||
| Net Profit Margin | -55.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bailee Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bailee Pharmaceuticals Private Limited
Bailee Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Kumar Choudhary Also directs: Bailee Medinova Private Limited | Director | 18 Nov 2021 | 4 Years 11 Months | Current |
| Abha Kumari Also directs: Bailee Medinova Private Limited | Director | 18 Nov 2021 | 4 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Bailee Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bailee Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bailee Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bailee Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Abha Kumari was appointed as Director on 18 Nov 2021.
Frequently asked questions
Bailee Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 November 2021 (5+ years old) and is registered under CIN U24290DL2021PTC390117.
Bailee Pharmaceuticals has 2 current directors:
- Suman Kumar Choudhary - Director
- Abha Kumari - Director
The latest financial statements of Bailee Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Bailee Pharmaceuticals is U24290DL2021PTC390117. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bailee Pharmaceuticals was incorporated on 18 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Abha Kumari was appointed as Director on 18 Nov 2021. Suman Kumar Choudhary was appointed as Director on 18 Nov 2021.
Yes, Bailee Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0026734).
Bailee Pharmaceuticals can be reached through the website baileepharmaceuticals.com. Its registered office is in Delhi, India.
The registered office of Bailee Pharmaceuticals is at H No.1479 Durga Mandir Block Tirthankar Nagar, Jain Nagar Village Karala, Delhi, India – 110081.
Bailee Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

